Skip to main content
SGHT
NASDAQ Industrial Applications And Services

Sight Sciences Beats Q3, Raises FY26 Revenue Guidance to $92M-$93M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$9.43
Mkt Cap
$533.252M
52W Low
$3.378
52W High
$10.06
52W Position info
179% above low
Off High info
6.3% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

SGHT has more than doubled off its 52-week low of $3.378 on elevated volume (2.2× avg).

Summary

Sight Sciences beat Q3 revenue estimates with $24.9M (+25%) and raised full-year 2026 revenue guidance to $92M-$93M, driven by a fast-scaling dry-eye business and sharply lower cash burn.


Key Events · Earnings and Guidance · SGHT

  • Q3 Revenue Beats, Up 25%

    Revenue came in at $24.9M versus $19.9M a year ago, ahead of the $23.5M consensus estimate.

  • FY26 Guidance Raised

    Full-year 2026 revenue guidance was lifted to $92M-$93M (19%-20% growth) from $88M-$92M; IDE guidance rose to ~$12M from $9M-$11M.

  • Dry Eye Scales Rapidly

    Interventional Dry Eye revenue reached $3.9M versus $0.2M a year ago, with gross margin up to 79% from 38%.

  • Cash Burn Cut 74%

    Q3 cash usage was $2.4M versus $9.1M a year ago; cash stood at $77.4M against $40.0M of total debt as of September 30, 2026.


Analysis · SGHT · Industrial Applications And Services

The headline is a Q3 beat, but the guidance raise and dry-eye ramp matter more. Revenue of $24.9M grew 25% and cleared the $23.5M consensus, and management lifted full-year revenue guidance to $92M-$93M from $88M-$92M. The dry-eye franchise is the real change: TearCare revenue jumped to $3.9M from $0.2M a year ago, and FY26 IDE guidance went to roughly $12M from $9M-$11M. Cash burn fell 74% to $2.4M for the quarter, leaving $77.4M of cash against $40.0M of debt — a runway story improving at the same time growth accelerates.

How filings like this one have moved

In the 30 days to Nov 4, 2026, 32.4% of the 2199 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SGHT was trading at $9.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $533.3M. The 52-week trading range was $3.38 to $10.06. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SGHT - Latest Insights

SGHT
Nov 04, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $9.43
Real-time Price: $9.43 info
Change: $0 (0%) info
Market Cap: $533.252M info
SGHT
Aug 19, 2026, 7:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $8.04
Real-time Price: $9.43 info
Change: +$1.39 (+17%) info
Market Cap: $533.252M info
SGHT
Aug 05, 2026, 4:49 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $5.86
Real-time Price: $9.43 info
Change: +$3.57 (+61%) info
Market Cap: $533.252M info
SGHT
Aug 05, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.25
Real-time Price: $9.43 info
Change: +$4.18 (+80%) info
Market Cap: $533.252M info
SGHT
Aug 04, 2026, 5:37 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $6.98
Real-time Price: $9.43 info
Change: +$2.45 (+35%) info
Market Cap: $533.252M info